CA
SYRS

CHI Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

CHI Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$5.12M Buy
1,299,359
+531,914
+69% +$2.1M 2.03% 13
2023
Q2 		$2.42M Hold
767,445
– – 0.73% 20
2023
Q1 		$2.05M Buy
+767,445
New +$2.05M 0.54% 21